CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
Haritha Mathsyaraja(Fred Hutch Cancer Center), Michael C. Ostrowski(Medical University of South Carolina), Clayton Deighan(The Ohio State University), Cynthia Timmers(Cancer Genetics (United States)), Lianbo Yu(The Ohio State University), Charles L. Shapiro(Tisch Hospital), David A. Taffany(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Jeffrey Chalmers(The Ohio State University), Katie Thies(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Gustavo Leone(The Ohio State University), José Javier Otero(Florida International University), Soledad Fernández(The Ohio State University), Tom Liu(Washington University in St. Louis)
Cited by 65
Related Papers
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k